Data_Sheet_2_Experience-Dependent Changes in Myelin Basic Protein Expression in Adult Visual and Somatosensory Cortex.pdf by Kathryn M. Murphy (8583285)

“…<p>An experience-driven increase in oligodendrocytes and myelin in the somatosensory cortex (S1) has emerged as a new marker of adult cortical plasticity. That finding contrasts with the view that myelin is a structural brake on plasticity, and that contributes to ending the critical period (CP) in the visual cortex (V1). …”

Data_Sheet_2_Experience-Dependent Changes in Myelin Basic Protein Expression in Adult Visual and Somatosensory Cortex.pdf by Kathryn M. Murphy (8583285)

“…<p>An experience-driven increase in oligodendrocytes and myelin in the somatosensory cortex (S1) has emerged as a new marker of adult cortical plasticity. That finding contrasts with the view that myelin is a structural brake on plasticity, and that contributes to ending the critical period (CP) in the visual cortex (V1). …”

Data_Sheet_1_Experience-Dependent Changes in Myelin Basic Protein Expression in Adult Visual and Somatosensory Cortex.PDF by Kathryn M. Murphy (8583285)

“…<p>An experience-driven increase in oligodendrocytes and myelin in the somatosensory cortex (S1) has emerged as a new marker of adult cortical plasticity. That finding contrasts with the view that myelin is a structural brake on plasticity, and that contributes to ending the critical period (CP) in the visual cortex (V1). …”

Validation of several <i>Lmx1a</i> target genes in <i>Lmx1a-dr/dr</i> embryos. by Elisa J. Hoekstra (290576)

“…<p>(A–D′) ISH showing that <i>Rspo2</i> is drastically down-regulated in sagittal E12.5 <i>Lmx1a-dr/dr</i> tissue (arrowheads). …”

An Improved Genome Assembly of Azadirachta indica A. Juss. by Binay Panda (768771)

“…The updated genome assembly (v2.0) yielded 3- and 3.5-fold increase in N50 and N75, respectively; 2.6-fold decrease in the total number of scaffolds; 1.25-fold increase in the number of valid transcriptome alignments; 13.4-fold less mis-assembly and 1.85-fold increase in the percentage repeat, over the earlier assembly (v1.0). …”

Baseline characteristics of the study subjects^a. by Ga Young Lee (1809919)

“…Meat intake also increased significantly in males in the ILR group at 3 months, but not in the IHR and CON groups (ILR: 49.4 ± 30.8, IHR: -52.2 ± 25.4, CON: -5.3 ± 30.3 g/d). ILR group showed a significant decrease in anxiety levels at 3 months, and their anxiety scores showed a negative association with meat intake (standardized <i>β</i> = -0.321, <i>p<</i>0.05). …”

A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model by Iart Luca Shytaj (157809)

“…Eleven macaques in the pre-AIDS stage of the disease were treated with a multidrug combination (highly intensified ART) consisting of two nucleosidic/nucleotidic reverse transcriptase inhibitors (emtricitabine and tenofovir), an integrase inhibitor (raltegravir), a protease inhibitor (ritonavir-boosted darunavir) and the CCR5 blocker maraviroc. …”

Intracellular calcium store release participates in choline mediated EB3 motility in the growth cone. by Justin R. King (793933)

The tangential momentum vs. the escape speed for the simulation results, which comprise nine combinations of parameters of one, two or three obstacles and obstacle radius values of... by Li Jiang (120930)

“…<p>The straight line is a linear fit to the data. We analyzed the points with an escape speed greater than 2.64 persons/sec. …”

Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF^V600E Mutant Melanom... by Brian D. Cholewa (1342671)

“…Furthermore, we have also identified the down-regulation of multiple proteasomal subunits, resulting in a significant decrease in 20S proteasome activity. …”

Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF^V600E Mutant Melanom... by Brian D. Cholewa (1342671)

“…Furthermore, we have also identified the down-regulation of multiple proteasomal subunits, resulting in a significant decrease in 20S proteasome activity. …”

Random forest analysis of the plasma metabolome. by Satoshi Kume (534079)

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A₂ Activity: A Randomized, Controlled Trial by Joel L. Johnson (525329)

“…protocolId=480848%2F010&studyId=74F5DB65-4661-4FA8-91D4-EBF78D769F24&compound=darapladib&type=Compound&letterrange=A-F</a></p></div>…”

Evaluation of Microflow Digital Imaging Particle Analysis for Sub-Visible Particles Formulated with an Opaque Vaccine Adjuvant by Grant E. Frahm (641684)

“…Reduced edge gradients and a decrease in measured particle sizes were noted as adjuvant concentrations increased. …”

Separase localizes to centrosomes in a microtubule-independent manner. by Fikret Gurkan Agircan (641709)

“…<p>(A) Cells were arrested at prometaphase with either 5 µM of STLC or 0.1 µg/ml of nocodazole. …”

(A) Scatter plot showing the amplitude of shifts in preferred orientation after adaptation as a function of the absolute difference between the control preferred orientation and th... by Narcis Ghisovan (94543)

“…The dashed lines in black and grey indicate the mean amplitude for attractive (17.3°) and repulsive (13.5°) shifts, respectively. …”

Transfection efficacy, expression of ATP7B post-transfection and post-transplantation. by Shenglin Chen (365519)

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”